Diana Langworthy

What's it Worth? A Journal Club Podcast

Explore clinical trials and enhance your skills in evidence evaluation with this podcast, perfect for healthcare students and professionals looking to improve their expertise.

Listen on Apple Podcasts

S3E6 (#22) Twice is Nice! Lenacapavir vs Daily Emtricitabine/Tenofovir for PrEP

S3 E6 • 47 mins • Jun 30, 2025

Charts

This show is not currently ranked in any charts.

Recent Episodes

Jun 30, 2025

S3E6 (#22) Twice is Nice! Lenacapavir vs Daily Emtricitabine/Tenofovir for PrEP

S3 E6 • 47 mins

Jun 3, 2025

S3E5 (#21) Empagliflozin Meets MASLD: Hope, Hype, or Hypothesis?

S3 E5 • 51 mins

May 20, 2025

S3E4 (#20) STOP in the name of eGFR? Continuing vs. stopping ACEi/ARB therapy in ESKD.

48 mins

Apr 23, 2025

S3E3 (#19.2) - Under Pressure! Portal hypertension showdown between carvedilol and classical non-selective beta blockers

S3 E3 • 36 mins

Apr 23, 2025

S3E2 (#19.1) - Seeing the forest for the trees in Hypertrophic Cardiomyopathy with the SEQUOIA Trial

S3 E2 • 28 mins

Language
English
Country
United States
Feed Host
Request an Update
Updates may take a few minutes.